Jiajia Jiang

1.7k total citations · 1 hit paper
44 papers, 1.2k citations indexed

About

Jiajia Jiang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiajia Jiang has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiajia Jiang's work include MicroRNA in disease regulation (19 papers), Extracellular vesicles in disease (15 papers) and Circular RNAs in diseases (15 papers). Jiajia Jiang is often cited by papers focused on MicroRNA in disease regulation (19 papers), Extracellular vesicles in disease (15 papers) and Circular RNAs in diseases (15 papers). Jiajia Jiang collaborates with scholars based in China, United States and Finland. Jiajia Jiang's co-authors include Wenrong Xu, Hui Qian, Xu Zhang, Hui Shi, Rong Li, Fan Zhang, Hui Qian, Hui Qian, Yongmin Yan and Zhen Guo and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Cellular and Molecular Life Sciences.

In The Last Decade

Jiajia Jiang

41 papers receiving 1.2k citations

Hit Papers

Exosomal circRNA: emerging insights into cancer progressi... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiajia Jiang China 16 963 761 90 75 66 44 1.2k
Zelian Qin China 12 536 0.6× 377 0.5× 64 0.7× 58 0.8× 104 1.6× 34 954
Donglin Luo China 17 599 0.6× 410 0.5× 62 0.7× 73 1.0× 128 1.9× 38 965
Xinyuan Zhao China 17 522 0.5× 312 0.4× 78 0.9× 42 0.6× 61 0.9× 36 749
Xinxing Zhu China 15 513 0.5× 299 0.4× 75 0.8× 75 1.0× 58 0.9× 36 747
Jiayi Huang China 4 867 0.9× 458 0.6× 58 0.6× 106 1.4× 60 0.9× 7 1.0k
Marina Gomzikova Russia 19 572 0.6× 271 0.4× 67 0.7× 101 1.3× 73 1.1× 42 854
Shuaixi Yang China 9 1.2k 1.2× 954 1.3× 72 0.8× 120 1.6× 45 0.7× 15 1.3k
Weitao Liu China 15 830 0.9× 638 0.8× 91 1.0× 87 1.2× 57 0.9× 29 1.2k
Gang‐Ming Zou China 15 537 0.6× 276 0.4× 46 0.5× 115 1.5× 88 1.3× 27 820

Countries citing papers authored by Jiajia Jiang

Since Specialization
Citations

This map shows the geographic impact of Jiajia Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajia Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajia Jiang more than expected).

Fields of papers citing papers by Jiajia Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajia Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajia Jiang. The network helps show where Jiajia Jiang may publish in the future.

Co-authorship network of co-authors of Jiajia Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajia Jiang. A scholar is included among the top collaborators of Jiajia Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajia Jiang. Jiajia Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Huiying, Xueyan Zang, Jiawei Tian, et al.. (2025). Small extracellular vesicles: crucial mediators for prostate cancer. Journal of Nanobiotechnology. 23(1). 230–230. 3 indexed citations
2.
Wang, Dongli, et al.. (2025). Small extracellular vesicles-based drug delivery systems for therapies of gastrointestinal tumours. Journal of drug targeting. 34(1). 13–29. 2 indexed citations
3.
Yu, Li, Tianshun Gao, Wenrong Xu, et al.. (2025). Exomeres and supermeres: Current advances and perspectives. Bioactive Materials. 50. 322–343. 1 indexed citations
4.
Shen, Ye, Xueyan Zang, Peipei Wu, et al.. (2025). Neutrophil membrane engineered human umbilical cord MSC-derived sEVs enhance anti-tumor efficacy for gastric cancer via delivering pentraxin 3. Journal of Controlled Release. 383. 113828–113828. 3 indexed citations
5.
Yang, Wenhui, et al.. (2025). Plant‐Derived Exosome‐Like Nanoparticles: Innovative Nanomedicine for Therapeutic Applications. Food Science & Nutrition. 13(9). e70974–e70974.
6.
Liu, Chang, Li Tang, Wenhui Yang, et al.. (2024). cGAS/STING pathway and gastrointestinal cancer: Mechanisms and diagnostic and therapeutic targets (Review). Oncology Reports. 53(1). 2 indexed citations
8.
Jiang, Liming, Yuexin Tong, Jiajia Jiang, & Dongxu Zhao. (2023). Individualized assessment predictive models for risk and overall survival in elderly patients of primary kidney cancer with bone metastases: A large population-based study. Frontiers in Medicine. 10. 1127625–1127625. 4 indexed citations
9.
Li, Rong, Xuejing Xu, Shuo Gao, et al.. (2023). Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis. Cancers. 15(23). 5556–5556. 2 indexed citations
10.
Jiang, Jiajia, et al.. (2023). Extensive spinal epidural abscess caused by Staphylococcus epidermidis: A case report and literature review. Frontiers in Surgery. 10. 1114729–1114729. 1 indexed citations
12.
Sun, Fengtian, et al.. (2022). Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy. Stem Cells International. 2022. 1–18. 92 indexed citations
13.
Jiang, Jiajia, et al.. (2022). Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects. Frontiers in Oncology. 12. 1037794–1037794. 9 indexed citations
14.
Wu, Peipei, et al.. (2022). Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Frontiers in Immunology. 13. 880523–880523. 17 indexed citations
15.
Cheng, Huiying, Can Huang, Xiang Gu, et al.. (2021). Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells. Journal of Inflammation Research. Volume 14. 5849–5862. 6 indexed citations
16.
Jiang, Jiajia, Rong Li, Junyi Wang, et al.. (2021). Circular RNA CDR1as Inhibits the Metastasis of Gastric Cancer through Targeting miR-876-5p/GNG7 Axis. Gastroenterology Research and Practice. 2021. 1–13. 17 indexed citations
17.
Yin, Ruofeng, Jiajia Jiang, Huimin Deng, et al.. (2020). miR-140-3p aggregates osteoporosis by targeting PTEN and activating PTEN/PI3K/AKT signaling pathway. Human Cell. 33(3). 569–581. 31 indexed citations
18.
Jiang, Jiajia, Wei Zhao, Qi Tang, et al.. (2019). Over expression of amphiregulin promoted malignant progression in gastric cancer. Pathology - Research and Practice. 215(10). 152576–152576. 14 indexed citations
20.
Jiang, Juncheng, Juncheng Jiang, Yong Pan, et al.. (2010). Life extension reliability analysis of decommissioned transportable seamless steel gas cylinders: A case study. Journal of Loss Prevention in the Process Industries. 24(1). 105–110. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026